English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Systematically linking drug susceptibility to cancer genome aberrations

Sos, M. L., & Thomas, R. K. (2009). Systematically linking drug susceptibility to cancer genome aberrations. Cell Cycle, 8(22), 3652-3656.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Sos, Martin L.1, Author           
Thomas, Roman K.1, Author           
Affiliations:
1Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656              

Content

show
hide
Free keywords: -
 Abstract: © 2009 Landes Bioscience

Details

show
hide
Language(s): eng - English
 Dates: 2009-11-15
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 437271
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Cell Cycle
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 8 (22) Sequence Number: - Start / End Page: 3652 - 3656 Identifier: -